Clinical Trial Update: Safety and Efficiency Study of Pioglitazone in Combination With Imatinib Mesylate to Treat Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the safety and efficacy of pioglitazone in combination with imatinib mesylate for chronic myelogenous leukemia. The trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelogenous Leukemia

Drugs mentioned

• Actos (Pioglitazone)
• Gleevec (Imatinib)

Snippet

Sponsor: Meng Li | Conditions: Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Phase 2 | Status: UNKNOWN